21世纪经济报道记者季媛媛 上海报道美国当地时间2月28日,美国食品药品监督管理局(FDA)在其官方网站发布了对于强生PFA导管VARIPULSE进行召回的公示。值得注意的是,此次行动被归类为纠正性召回,而非产品撤回。FDA要求对该产品的说明书进行更新,以对医生和手术增加更详细的建议和指导。此前,出于谨慎考虑,强生曾宣布临时暂停VARIPULSE在美国进行外部临床评估,并对潜在的器械、手术和患者等...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.